Ignite Creation Date:
2025-12-24 @ 10:59 PM
Ignite Modification Date:
2026-01-02 @ 4:31 PM
Study NCT ID:
NCT00886769
Status:
TERMINATED
Last Update Posted:
2017-03-29
First Post:
2009-04-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-07
Start Date Type:
None
Primary Completion Date:
2010-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-01
Completion Date Type:
ACTUAL
First Submit Date:
2009-04-22
First Submit QC Date:
None
Study First Post Date:
2009-04-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2011-11-21
Results First Submit QC Date:
None
Results First Post Date:
2012-04-09
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-02-28
Last Update Post Date:
2017-03-29
Last Update Post Date Type:
ACTUAL